The purpose of this research study is to measure adherence to the study drug (Carac) for the treatment of actinic keratoses.
The purpose of this research study is to measure adherence to the study drug for the treatment of actinic keratoses. The study drug is 5-Fluorouracil (Carac®); it will be used in this study to treat actinic keratoses on the face and anterior scalp. This proposed study will evaluate adherence to topical Carac® in 20 adults age 50 or greater with actinic keratoses from a clinic population. Adherence data will be collected by the MEMS cap (Medication Event Monitoring System
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
20
Subjects will apply the smallest amount of study medication possible that is just sufficient to cover all of the affected areas daily to AK lesions
Wake Forest University Health Sciences Dermatology
Winston-Salem, North Carolina, United States
Adherence to Carac® in Subjects With Moderate to Severe Actinic Keratosis.
Measure of adherence by MEMS caps and the % of total prescribed doses that were actually used
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.